中芯(00981.HK)低開逾3%重失10天線 末季少賺28%
中芯國際(00981.HK)去年末季少賺28%,今早股價低開3.4%報17.4元,重失10天(約17.56元)及20天線(約17.58元),市前成交167萬股。
中芯公布,去年末季純利3.86億美元,按年及按季分別跌27.8%及18%。期內,,總銷售收入16.21億美元,按年增加2.6%,按季下降15%。毛利5.19億美元,按年及按季分別降6%及30%;毛利率降至32%,低於去年第三季及去年同期分別為38.9%及35%。至於2022年全年純利按年增長6.8%至18.18億美元,總銷售收入按年升33.6%至72.73億美元。公司預期,今年首季收入按季下降10%至12%;毛利率介乎19%至21%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.